Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Pharma and Healthcare
Revenue, means the sales value of Pharma and Healthcare
This report studies sales (consumption) of Pharma and Healthcare in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
GE Healthcare
Siemens Healthcare
Philips Healthcare
Boston
Smith & Nephew
Medtronic
Stryker
Johnson and Johnson
Baxter International
Roche
Pfizer
Bayer
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Healthcare Pharma
Healthcare Device
Split by applications, this report focuses on sales, market share and growth rate of Pharma and Healthcare in each application, can be divided into
Home
Hospital
United States Pharma and Healthcare Market Report 2017
1 Pharma and Healthcare Overview
1.1 Product Overview and Scope of Pharma and Healthcare
1.2 Classification of Pharma and Healthcare
1.2.1 Healthcare Pharma
1.2.2 Healthcare Device
1.3 Application of Pharma and Healthcare
1.3.1 Home
1.3.2 Hospital
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Pharma and Healthcare (2012-2022)
1.4.1 United States Pharma and Healthcare Sales and Growth Rate (2012-2022)
1.4.2 United States Pharma and Healthcare Revenue and Growth Rate (2012-2022)
2 United States Pharma and Healthcare Competition by Manufacturers
2.1 United States Pharma and Healthcare Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pharma and Healthcare Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pharma and Healthcare Average Price by Manufactures (2015 and 2016)
2.4 Pharma and Healthcare Market Competitive Situation and Trends
2.4.1 Pharma and Healthcare Market Concentration Rate
2.4.2 Pharma and Healthcare Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Pharma and Healthcare Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Pharma and Healthcare Sales and Market Share by States (2012-2017)
3.2 United States Pharma and Healthcare Revenue and Market Share by States (2012-2017)
3.3 United States Pharma and Healthcare Price by States (2012-2017)
4 United States Pharma and Healthcare Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Pharma and Healthcare Sales and Market Share by Type (2012-2017)
4.2 United States Pharma and Healthcare Revenue and Market Share by Type (2012-2017)
4.3 United States Pharma and Healthcare Price by Type (2012-2017)
4.4 United States Pharma and Healthcare Sales Growth Rate by Type (2012-2017)
5 United States Pharma and Healthcare Sales (Volume) by Application (2012-2017)
5.1 United States Pharma and Healthcare Sales and Market Share by Application (2012-2017)
5.2 United States Pharma and Healthcare Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Pharma and Healthcare Manufacturers Profiles/Analysis
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Pharma and Healthcare Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthcare
6.2.2 Pharma and Healthcare Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Siemens Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Philips Healthcare
6.3.2 Pharma and Healthcare Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Philips Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Boston
6.4.2 Pharma and Healthcare Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Boston Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Smith & Nephew
6.5.2 Pharma and Healthcare Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Smith & Nephew Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Medtronic
6.6.2 Pharma and Healthcare Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Medtronic Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Stryker
6.7.2 Pharma and Healthcare Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Stryker Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Johnson and Johnson
6.8.2 Pharma and Healthcare Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Johnson and Johnson Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Baxter International
6.9.2 Pharma and Healthcare Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Baxter International Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Roche
6.10.2 Pharma and Healthcare Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Roche Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Bayer
7 Pharma and Healthcare Manufacturing Cost Analysis
7.1 Pharma and Healthcare Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pharma and Healthcare
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Pharma and Healthcare Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pharma and Healthcare Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Pharma and Healthcare Market Forecast (2017-2022)
11.1 United States Pharma and Healthcare Sales, Revenue Forecast (2017-2022)
11.2 United States Pharma and Healthcare Sales Forecast by Type (2017-2022)
11.3 United States Pharma and Healthcare Sales Forecast by Application (2017-2022)
11.4 Pharma and Healthcare Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Pharma and Healthcare
Table Classification of Pharma and Healthcare
Figure United States Sales Market Share of Pharma and Healthcare by Type in 2015
Figure Healthcare Pharma Picture
Figure Healthcare Device Picture
Table Application of Pharma and Healthcare
Figure United States Sales Market Share of Pharma and Healthcare by Application in 2015
Figure Home Examples
Figure Hospital Examples
Figure United States Pharma and Healthcare Sales and Growth Rate (2012-2022)
Figure United States Pharma and Healthcare Revenue and Growth Rate (2012-2022)
Table United States Pharma and Healthcare Sales of Key Manufacturers (2015 and 2016)
Table United States Pharma and Healthcare Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pharma and Healthcare Sales Share by Manufacturers
Figure 2016 Pharma and Healthcare Sales Share by Manufacturers
Table United States Pharma and Healthcare Revenue by Manufacturers (2015 and 2016)
Table United States Pharma and Healthcare Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pharma and Healthcare Revenue Share by Manufacturers
Table 2016 United States Pharma and Healthcare Revenue Share by Manufacturers
Table United States Market Pharma and Healthcare Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pharma and Healthcare Average Price of Key Manufacturers in 2015
Figure Pharma and Healthcare Market Share of Top 3 Manufacturers
Figure Pharma and Healthcare Market Share of Top 5 Manufacturers
Table United States Pharma and Healthcare Sales by States (2012-2017)
Table United States Pharma and Healthcare Sales Share by States (2012-2017)
Figure United States Pharma and Healthcare Sales Market Share by States in 2015
Table United States Pharma and Healthcare Revenue and Market Share by States (2012-2017)
Table United States Pharma and Healthcare Revenue Share by States (2012-2017)
Figure Revenue Market Share of Pharma and Healthcare by States (2012-2017)
Table United States Pharma and Healthcare Price by States (2012-2017)
Table United States Pharma and Healthcare Sales by Type (2012-2017)
Table United States Pharma and Healthcare Sales Share by Type (2012-2017)
Figure United States Pharma and Healthcare Sales Market Share by Type in 2015
Table United States Pharma and Healthcare Revenue and Market Share by Type (2012-2017)
Table United States Pharma and Healthcare Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pharma and Healthcare by Type (2012-2017)
Table United States Pharma and Healthcare Price by Type (2012-2017)
Figure United States Pharma and Healthcare Sales Growth Rate by Type (2012-2017)
Table United States Pharma and Healthcare Sales by Application (2012-2017)
Table United States Pharma and Healthcare Sales Market Share by Application (2012-2017)
Figure United States Pharma and Healthcare Sales Market Share by Application in 2015
Table United States Pharma and Healthcare Sales Growth Rate by Application (2012-2017)
Figure United States Pharma and Healthcare Sales Growth Rate by Application (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GE Healthcare Pharma and Healthcare Sales Market Share (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Siemens Healthcare Pharma and Healthcare Sales Market Share (2012-2017)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Philips Healthcare Pharma and Healthcare Sales Market Share (2012-2017)
Table Boston Basic Information List
Table Boston Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boston Pharma and Healthcare Sales Market Share (2012-2017)
Table Smith & Nephew Basic Information List
Table Smith & Nephew Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Smith & Nephew Pharma and Healthcare Sales Market Share (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Medtronic Pharma and Healthcare Sales Market Share (2012-2017)
Table Stryker Basic Information List
Table Stryker Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Stryker Pharma and Healthcare Sales Market Share (2012-2017)
Table Johnson and Johnson Basic Information List
Table Johnson and Johnson Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson and Johnson Pharma and Healthcare Sales Market Share (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Baxter International Pharma and Healthcare Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Pharma and Healthcare Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Pharma and Healthcare Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Bayer Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharma and Healthcare
Figure Manufacturing Process Analysis of Pharma and Healthcare
Figure Pharma and Healthcare Industrial Chain Analysis
Table Raw Materials Sources of Pharma and Healthcare Major Manufacturers in 2015
Table Major Buyers of Pharma and Healthcare
Table Distributors/Traders List
Figure United States Pharma and Healthcare Production and Growth Rate Forecast (2017-2022)
Figure United States Pharma and Healthcare Revenue and Growth Rate Forecast (2017-2022)
Table United States Pharma and Healthcare Production Forecast by Type (2017-2022)
Table United States Pharma and Healthcare Consumption Forecast by Application (2017-2022)
Table United States Pharma and Healthcare Sales Forecast by States (2017-2022)
Table United States Pharma and Healthcare Sales Share Forecast by States (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...